Teladoc Health (TDOC) to Release Quarterly Earnings on Wednesday

Teladoc Health (NYSE:TDOC) is projected to post its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect Teladoc Health to post earnings of ($0.19) per share and revenue of $635.3290 million for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, February 25, 2026 at 5:00 PM ET.

Teladoc Health Stock Performance

Shares of NYSE TDOC opened at $4.55 on Wednesday. The company has a current ratio of 2.70, a quick ratio of 2.60 and a debt-to-equity ratio of 0.71. The company has a 50 day simple moving average of $6.40 and a two-hundred day simple moving average of $7.32. Teladoc Health has a 12 month low of $4.40 and a 12 month high of $14.61. The stock has a market cap of $807.49 million, a price-to-earnings ratio of -3.55 and a beta of 2.12.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on TDOC shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Teladoc Health in a report on Monday, December 29th. Evercore dropped their price objective on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a report on Thursday, October 30th. BMO Capital Markets initiated coverage on shares of Teladoc Health in a research report on Thursday, November 13th. They set a “market perform” rating and a $8.00 price target for the company. Barclays initiated coverage on shares of Teladoc Health in a research note on Tuesday, December 9th. They set an “equal weight” rating and a $8.50 target price on the stock. Finally, Zacks Research cut shares of Teladoc Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. Three equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $9.12.

Insider Activity

In other news, insider Adam C. Vandervoort sold 5,720 shares of Teladoc Health stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total value of $42,842.80. Following the completion of the sale, the insider owned 80,732 shares of the company’s stock, valued at $604,682.68. The trade was a 6.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Fernando M. Rodrigues sold 4,209 shares of the business’s stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total transaction of $31,483.32. The SEC filing for this sale provides additional information. Insiders sold a total of 33,288 shares of company stock valued at $251,684 over the last quarter. Insiders own 0.58% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently bought and sold shares of TDOC. IFP Advisors Inc boosted its stake in shares of Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after buying an additional 3,210 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in Teladoc Health by 177.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after acquiring an additional 2,810 shares in the last quarter. Van ECK Associates Corp increased its position in shares of Teladoc Health by 101.4% in the 4th quarter. Van ECK Associates Corp now owns 9,150 shares of the health services provider’s stock worth $64,000 after purchasing an additional 4,607 shares during the last quarter. Johnson Financial Group Inc. raised its stake in shares of Teladoc Health by 41,045.8% in the 3rd quarter. Johnson Financial Group Inc. now owns 9,875 shares of the health services provider’s stock valued at $76,000 after purchasing an additional 9,851 shares in the last quarter. Finally, Cibc World Markets Corp bought a new position in shares of Teladoc Health during the fourth quarter worth about $82,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.